Research location
Fraser
Michigan, United States
Advertisement
Research activity in Fraser
Michigan, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Fraser
10 linked trials · page 1 of 1A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With GlaucomaNCT06822738 · 2025-02-11 · 1 site observation
RECRUITING
Hydrus® Microstent New Enrollment Post-Approval StudyNCT04553523 · 2020-08-25 · 1 site observation
RECRUITING
Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous PatientsNCT05397600 · 2022-06-22 · 1 site observation
COMPLETED
Safety and Effectiveness of the Hydrus MicrostentNCT05198297 · 2021-12-13 · 1 site observation
TERMINATED
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular HypertensionNCT04499248 · 2020-11-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Long-term Safety and Efficacy Extension Trial of Bimatoprost SRNCT03891446 · 2019-03-27 · 1 site observation
COMPLETED
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular HypertensionNCT03850782 · 2019-02-28 · 1 site observation
COMPLETED
Post Approval Study of the CyPass SystemNCT03273907 · 2017-10-12 · 1 site observation
TERMINATED
A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular HypertensionNCT02636946 · 2016-02-24 · 1 site observation
COMPLETED
Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular HypertensionNCT02507687 · 2015-08-27 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.